Open Search

POBEVCY® Bevacizumab（400mg/16mL）

Please use it under the guidance of experienced doctors.

BAT1706 (Avzivi ® , bevacizumab) is ahumanized monoclonal antibody that targets VEGF. It specifically binds to VEGFand blocks the binding of VEGF to its receptor, thereby reducingneovascularization, inducing the degradation of existing blood vessels, andthereby inhibiting tumor growth. The brand name for BAT1706 in the EU and theUnited States is Avzivi ® .

Prescribing Information POBEVCY®

Indications

In the United States, Avzivi® is indicated for the treatment of 1) Metastatic colorectal cancer, 2) non-squamous non-small cell lung cancer, 3) glioblastoma in adults, 4) Metastatic renal cell carcinoma, 5) cervical cancer, 6) Epithelial ovarian, fallopian tube, or primary peritoneal cancer. In the Europe, Avzivi® is indicated for the treatment of 1) Metastatic carcinoma of the colon or rectum, 2) Metastatic breast cancer, 3) non-small cell lung cancer, 4) renal cell cancer, 5) epithelial ovarian, fallopian tube, or primary peritoneal cancer, 6) carcinoma of the cervix.

WeChat

Z6·尊龙凯时「中国」官方网站

POBEVCY® Bevacizumab（400mg/16mL）

Please use it under the guidance of experienced doctors.

Indications